Critical contributions of primate models for biopharmaceutical drug development:
"In continuation of the Covance Primate Symposium Series, the 17th Covance Primate Symposium took place in Münster during April 16 and 17, 2008. Altogether, 131 participants -- the largest attendance so far -- representing 13 countries and 56 organisations assembled for this symposium. The 2008...
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Münster ; New York, NY ; München ; Berlin
Waxmann
2008
|
| Schlagworte: | |
| Online-Zugang: | Inhaltstext Inhaltsverzeichnis |
| Zusammenfassung: | "In continuation of the Covance Primate Symposium Series, the 17th Covance Primate Symposium took place in Münster during April 16 and 17, 2008. Altogether, 131 participants -- the largest attendance so far -- representing 13 countries and 56 organisations assembled for this symposium. The 2008 Primate Symposium focussed on 'Critical Contributions of Primate Models for Biopharmaceutical Drug Development'. This is obviously a very timely topic since numerous biopharmaceuticals, in particular monoclonal antibodies, are in preclinical development and, in many instances, nonhuman primates represent the relevant model. Also, there are efforts, at least in Europe, to substantially change the environmental conditions for primates in research which will also impact pharmaceutical drug development. Beyond this, current topics such as developmental and juvenile toxicity testing and the perspectives of stem cell-derived therapeutics were also covered. In general, it is assumed that the demand for research on nonhuman primates in preclinical development will increase over the coming years. Expert speakers discussed four topics in particular, i.e.:stem cell-derived therapeutics as a potential new horizon for new therapeutic drugs; the European environment for primate research and whether this presents a barrier or rather an opportunity; new approaches for developmental and juvenile toxicity testing in nonhuman primates; and current challenges in biopharmaceutical drug development."--Back cover. |
| Beschreibung: | Literaturangaben |
| Beschreibung: | 184 S. Ill., graph. Darst. 22 cm |
| ISBN: | 9783830921042 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV035308610 | ||
| 003 | DE-604 | ||
| 005 | 20091214 | ||
| 007 | t | ||
| 008 | 090212s2008 ad|| |||| 00||| eng d | ||
| 016 | 7 | |a 992438756 |2 DE-101 | |
| 020 | |a 9783830921042 |c Pp. : EUR 39.90 |9 978-3-8309-2104-2 | ||
| 024 | 3 | |a 9783830921042 | |
| 035 | |a (OCoLC)432240196 | ||
| 035 | |a (DE-599)DNB992438756 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-12 | ||
| 050 | 0 | |a RM301 | |
| 082 | 0 | |a 615.1922 | |
| 084 | |a 610 |2 sdnb | ||
| 245 | 1 | 0 | |a Critical contributions of primate models for biopharmaceutical drug development |c Gerhard F. Weinbauer ; Friedhelm Vogel (ed.) |
| 264 | 1 | |a Münster ; New York, NY ; München ; Berlin |b Waxmann |c 2008 | |
| 300 | |a 184 S. |b Ill., graph. Darst. |c 22 cm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Literaturangaben | ||
| 520 | 3 | |a "In continuation of the Covance Primate Symposium Series, the 17th Covance Primate Symposium took place in Münster during April 16 and 17, 2008. Altogether, 131 participants -- the largest attendance so far -- representing 13 countries and 56 organisations assembled for this symposium. The 2008 Primate Symposium focussed on 'Critical Contributions of Primate Models for Biopharmaceutical Drug Development'. This is obviously a very timely topic since numerous biopharmaceuticals, in particular monoclonal antibodies, are in preclinical development and, in many instances, nonhuman primates represent the relevant model. Also, there are efforts, at least in Europe, to substantially change the environmental conditions for primates in research which will also impact pharmaceutical drug development. Beyond this, current topics such as developmental and juvenile toxicity testing and the perspectives of stem cell-derived therapeutics were also covered. In general, it is assumed that the demand for research on nonhuman primates in preclinical development will increase over the coming years. Expert speakers discussed four topics in particular, i.e.:stem cell-derived therapeutics as a potential new horizon for new therapeutic drugs; the European environment for primate research and whether this presents a barrier or rather an opportunity; new approaches for developmental and juvenile toxicity testing in nonhuman primates; and current challenges in biopharmaceutical drug development."--Back cover. | |
| 650 | 4 | |a Arzneimittelentwicklung - Primaten - Versuchstiere - Kongress - Münster <Westfalen, 2008> | |
| 650 | 4 | |a Animal models in research |v Congresses | |
| 650 | 4 | |a Biopharmaceutics |v Congresses | |
| 650 | 4 | |a Drug Evaluation, Preclinical |x methods |v Congresses | |
| 650 | 4 | |a Drugs |x Testing |v Congresses | |
| 650 | 4 | |a Models, Animal |v Congresses | |
| 650 | 4 | |a Primates |v Congresses | |
| 650 | 0 | 7 | |a Tiermodell |0 (DE-588)4140660-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Versuchstiere |0 (DE-588)4078861-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Primaten |0 (DE-588)4047256-5 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 2008 |z Münster (Westf) |2 gnd-content | |
| 689 | 0 | 0 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 0 | 1 | |a Primaten |0 (DE-588)4047256-5 |D s |
| 689 | 0 | 2 | |a Versuchstiere |0 (DE-588)4078861-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Primaten |0 (DE-588)4047256-5 |D s |
| 689 | 1 | 1 | |a Tiermodell |0 (DE-588)4140660-6 |D s |
| 689 | 1 | 2 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 1 | |C b |5 DE-604 | |
| 700 | 1 | |a Weinbauer, Gerhard F. |4 edt | |
| 856 | 4 | 2 | |q text/html |u http://deposit.dnb.de/cgi-bin/dokserv?id=3237578&prov=M&dok_var=1&dok_ext=htm |3 Inhaltstext |
| 856 | 4 | 2 | |m DNB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017113381&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-017113381 | |
Datensatz im Suchindex
| _version_ | 1805091887662497792 |
|---|---|
| adam_text |
CONTENTS PREFACE 7 STEIN CELL-DERIVED THERAPEUTICS: A NEW HORIZON?
XENOTRANSPLANTATION OF TESTICULAR TISSUE AND GERM CELL TRANSPLANTATION
PROVIDE NOVEL EXPERIMENTAL STRATEGIES FOR TOXICITY TESTS ON PRIMATE
TESTICULAR STERN CELLS 11 STEFAN SCHLAFT PLURIPOTENT PRIMATE STERN CELLS
FOR BIOMEDICAL RESEARCH, DEVELOPMENT OF REGENERATIVE THERAPIES AND DRUG
SCREENING 25 ULRICH MARTIN THE EUROPEAN ENVIRONMENT FOR PRIMATE
RESEARCH: BARRIER OR OPPORTUNITY? EUROPEAN PRIMATE NETWORK - EUPRIM-NET:
A NETWORK COORDINATED BY THE GERMAN PRIMATE CENTRE FOCUSING ON
SPECIALIZED INFIASTRUCTURES AND PROCEDURES FOR BIOLOGICAL AND BIOMEDICAL
RESEARCH 41 STEFAN TREUE, INES LEIN, ROBERT TEEPE THE NEW EUROPEAN
HOUSING REGULATIONS FOR NONHUMAN PRIMATES: OPPORTUNITIES AND CHALLENGES
53 WOLFGANG MUELLER VIEWS AND OBJECTIVES OF THE RESEARCH & DEVELOPMENT
BASED PHARMACEUTICAL INDUSTRY IN EUROPE WITH SPECIAL FOCUS ON RESEARCH
ON NONHUMAN PRIMATES 75 GABRIELE KUESTERS BIBLIOGRAFISCHE INFORMATIONEN
HTTP://D-NB.INFO/992438756 DIGITALISIERT DURCH NEW APPROACHES FOR
DEVELOPMENTAL AND JUVENILE TOXICITY TESTING IN NONHUMAN PRIMATES
JUVENILE TOXICITY TESTING AND A ROLE FOR THE NONHUMAN PRIMATE 83
MARKE.HURTT DEVELOPMENTAL/REPRODUCTIVE TOXICOLOGY STUDY DESIGN OPTIONS
FOR MONOCLONAL ANTIBODIES 101 JANE STEWART AUTOMATED ASSESSMENT OF
COGNITIVE FUNCTION IN MACAQUES 113 MERLE G. PAULE POSTAATAL BONE GROWTH
AND MATURATION ASSESSMENT IN THE CYNOMOLGUS MONKEY MODEL 125 MARC
NIEHAFF, GERHARD F. WEINBAUER CURRENT CHALLENGES IN BIOPHARMACEUTICAL
DRUG DEVELOPMENT SAFETY PHARMACOLOGY TESTING OF BIOPHARMACEUTICALS 143
ALEXANDER BREIDENBACH, LIUDMILA POLONCHUK, CHRISTIAN FREICHEL, ANDREA
GREITER-WILKE, HENRY HOLZGREFE, THOMAS WEISER PRACTICAL CONSIDERATIONS
FOR TESTING BIOPHARMACEUTICALS IN NONHUMAN PRIMATES 161 WERNER FRINGS
CONTRIBUTORS 175 PROGRAMME 177 INDEX 181 |
| any_adam_object | 1 |
| author2 | Weinbauer, Gerhard F. |
| author2_role | edt |
| author2_variant | g f w gf gfw |
| author_facet | Weinbauer, Gerhard F. |
| building | Verbundindex |
| bvnumber | BV035308610 |
| callnumber-first | R - Medicine |
| callnumber-label | RM301 |
| callnumber-raw | RM301 |
| callnumber-search | RM301 |
| callnumber-sort | RM 3301 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| ctrlnum | (OCoLC)432240196 (DE-599)DNB992438756 |
| dewey-full | 615.1922 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.1922 |
| dewey-search | 615.1922 |
| dewey-sort | 3615.1922 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 c 4500</leader><controlfield tag="001">BV035308610</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20091214</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">090212s2008 ad|| |||| 00||| eng d</controlfield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">992438756</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783830921042</subfield><subfield code="c">Pp. : EUR 39.90</subfield><subfield code="9">978-3-8309-2104-2</subfield></datafield><datafield tag="024" ind1="3" ind2=" "><subfield code="a">9783830921042</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)432240196</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB992438756</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-12</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM301</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.1922</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Critical contributions of primate models for biopharmaceutical drug development</subfield><subfield code="c">Gerhard F. Weinbauer ; Friedhelm Vogel (ed.)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Münster ; New York, NY ; München ; Berlin</subfield><subfield code="b">Waxmann</subfield><subfield code="c">2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">184 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield><subfield code="c">22 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">"In continuation of the Covance Primate Symposium Series, the 17th Covance Primate Symposium took place in Münster during April 16 and 17, 2008. Altogether, 131 participants -- the largest attendance so far -- representing 13 countries and 56 organisations assembled for this symposium. The 2008 Primate Symposium focussed on 'Critical Contributions of Primate Models for Biopharmaceutical Drug Development'. This is obviously a very timely topic since numerous biopharmaceuticals, in particular monoclonal antibodies, are in preclinical development and, in many instances, nonhuman primates represent the relevant model. Also, there are efforts, at least in Europe, to substantially change the environmental conditions for primates in research which will also impact pharmaceutical drug development. Beyond this, current topics such as developmental and juvenile toxicity testing and the perspectives of stem cell-derived therapeutics were also covered. In general, it is assumed that the demand for research on nonhuman primates in preclinical development will increase over the coming years. Expert speakers discussed four topics in particular, i.e.:stem cell-derived therapeutics as a potential new horizon for new therapeutic drugs; the European environment for primate research and whether this presents a barrier or rather an opportunity; new approaches for developmental and juvenile toxicity testing in nonhuman primates; and current challenges in biopharmaceutical drug development."--Back cover.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Arzneimittelentwicklung - Primaten - Versuchstiere - Kongress - Münster <Westfalen, 2008></subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Animal models in research</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biopharmaceutics</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation, Preclinical</subfield><subfield code="x">methods</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Testing</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Models, Animal</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Primates</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Tiermodell</subfield><subfield code="0">(DE-588)4140660-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Versuchstiere</subfield><subfield code="0">(DE-588)4078861-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Primaten</subfield><subfield code="0">(DE-588)4047256-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">2008</subfield><subfield code="z">Münster (Westf)</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Primaten</subfield><subfield code="0">(DE-588)4047256-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Versuchstiere</subfield><subfield code="0">(DE-588)4078861-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Primaten</subfield><subfield code="0">(DE-588)4047256-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Tiermodell</subfield><subfield code="0">(DE-588)4140660-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="C">b</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Weinbauer, Gerhard F.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="q">text/html</subfield><subfield code="u">http://deposit.dnb.de/cgi-bin/dokserv?id=3237578&prov=M&dok_var=1&dok_ext=htm</subfield><subfield code="3">Inhaltstext</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017113381&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-017113381</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 2008 Münster (Westf) gnd-content |
| genre_facet | Konferenzschrift 2008 Münster (Westf) |
| id | DE-604.BV035308610 |
| illustrated | Illustrated |
| indexdate | 2024-07-20T10:02:51Z |
| institution | BVB |
| isbn | 9783830921042 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-017113381 |
| oclc_num | 432240196 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-12 |
| owner_facet | DE-19 DE-BY-UBM DE-12 |
| physical | 184 S. Ill., graph. Darst. 22 cm |
| publishDate | 2008 |
| publishDateSearch | 2008 |
| publishDateSort | 2008 |
| publisher | Waxmann |
| record_format | marc |
| spelling | Critical contributions of primate models for biopharmaceutical drug development Gerhard F. Weinbauer ; Friedhelm Vogel (ed.) Münster ; New York, NY ; München ; Berlin Waxmann 2008 184 S. Ill., graph. Darst. 22 cm txt rdacontent n rdamedia nc rdacarrier Literaturangaben "In continuation of the Covance Primate Symposium Series, the 17th Covance Primate Symposium took place in Münster during April 16 and 17, 2008. Altogether, 131 participants -- the largest attendance so far -- representing 13 countries and 56 organisations assembled for this symposium. The 2008 Primate Symposium focussed on 'Critical Contributions of Primate Models for Biopharmaceutical Drug Development'. This is obviously a very timely topic since numerous biopharmaceuticals, in particular monoclonal antibodies, are in preclinical development and, in many instances, nonhuman primates represent the relevant model. Also, there are efforts, at least in Europe, to substantially change the environmental conditions for primates in research which will also impact pharmaceutical drug development. Beyond this, current topics such as developmental and juvenile toxicity testing and the perspectives of stem cell-derived therapeutics were also covered. In general, it is assumed that the demand for research on nonhuman primates in preclinical development will increase over the coming years. Expert speakers discussed four topics in particular, i.e.:stem cell-derived therapeutics as a potential new horizon for new therapeutic drugs; the European environment for primate research and whether this presents a barrier or rather an opportunity; new approaches for developmental and juvenile toxicity testing in nonhuman primates; and current challenges in biopharmaceutical drug development."--Back cover. Arzneimittelentwicklung - Primaten - Versuchstiere - Kongress - Münster <Westfalen, 2008> Animal models in research Congresses Biopharmaceutics Congresses Drug Evaluation, Preclinical methods Congresses Drugs Testing Congresses Models, Animal Congresses Primates Congresses Tiermodell (DE-588)4140660-6 gnd rswk-swf Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf Versuchstiere (DE-588)4078861-1 gnd rswk-swf Primaten (DE-588)4047256-5 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 2008 Münster (Westf) gnd-content Arzneimittelentwicklung (DE-588)4143176-5 s Primaten (DE-588)4047256-5 s Versuchstiere (DE-588)4078861-1 s DE-604 Tiermodell (DE-588)4140660-6 s b DE-604 Weinbauer, Gerhard F. edt text/html http://deposit.dnb.de/cgi-bin/dokserv?id=3237578&prov=M&dok_var=1&dok_ext=htm Inhaltstext DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017113381&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Critical contributions of primate models for biopharmaceutical drug development Arzneimittelentwicklung - Primaten - Versuchstiere - Kongress - Münster <Westfalen, 2008> Animal models in research Congresses Biopharmaceutics Congresses Drug Evaluation, Preclinical methods Congresses Drugs Testing Congresses Models, Animal Congresses Primates Congresses Tiermodell (DE-588)4140660-6 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd Versuchstiere (DE-588)4078861-1 gnd Primaten (DE-588)4047256-5 gnd |
| subject_GND | (DE-588)4140660-6 (DE-588)4143176-5 (DE-588)4078861-1 (DE-588)4047256-5 (DE-588)1071861417 |
| title | Critical contributions of primate models for biopharmaceutical drug development |
| title_auth | Critical contributions of primate models for biopharmaceutical drug development |
| title_exact_search | Critical contributions of primate models for biopharmaceutical drug development |
| title_full | Critical contributions of primate models for biopharmaceutical drug development Gerhard F. Weinbauer ; Friedhelm Vogel (ed.) |
| title_fullStr | Critical contributions of primate models for biopharmaceutical drug development Gerhard F. Weinbauer ; Friedhelm Vogel (ed.) |
| title_full_unstemmed | Critical contributions of primate models for biopharmaceutical drug development Gerhard F. Weinbauer ; Friedhelm Vogel (ed.) |
| title_short | Critical contributions of primate models for biopharmaceutical drug development |
| title_sort | critical contributions of primate models for biopharmaceutical drug development |
| topic | Arzneimittelentwicklung - Primaten - Versuchstiere - Kongress - Münster <Westfalen, 2008> Animal models in research Congresses Biopharmaceutics Congresses Drug Evaluation, Preclinical methods Congresses Drugs Testing Congresses Models, Animal Congresses Primates Congresses Tiermodell (DE-588)4140660-6 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd Versuchstiere (DE-588)4078861-1 gnd Primaten (DE-588)4047256-5 gnd |
| topic_facet | Arzneimittelentwicklung - Primaten - Versuchstiere - Kongress - Münster <Westfalen, 2008> Animal models in research Congresses Biopharmaceutics Congresses Drug Evaluation, Preclinical methods Congresses Drugs Testing Congresses Models, Animal Congresses Primates Congresses Tiermodell Arzneimittelentwicklung Versuchstiere Primaten Konferenzschrift 2008 Münster (Westf) |
| url | http://deposit.dnb.de/cgi-bin/dokserv?id=3237578&prov=M&dok_var=1&dok_ext=htm http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017113381&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT weinbauergerhardf criticalcontributionsofprimatemodelsforbiopharmaceuticaldrugdevelopment |